GA-EPO Trademark

Trademark Overview


On Tuesday, June 2, 1998, a trademark application was filed for GA-EPO with the United States Patent and Trademark Office. The USPTO has given the GA-EPO trademark a serial number of 75494752. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, July 26, 2003. This trademark is owned by Transkaryotic Therapies, Inc.. The GA-EPO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, gastrointestinal disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous systems, autoimmune disorders and other disorders of the immune system, cardiovascular disorders, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients

General Information


Serial Number75494752
Word MarkGA-EPO
Filing DateTuesday, June 2, 1998
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSaturday, July 26, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 2, 2000

Trademark Statements


Goods and ServicesPharmaceuticals and biologics for use in the treatment of genetic disorders, cancer, hematologic disorders, endocrine disorders, gastrointestinal disorders, reproductive dysfunction, short stature, diabetes, metabolic disorders, disorders of the central nervous systems, autoimmune disorders and other disorders of the immune system, cardiovascular disorders, infectious diseases and enzyme deficiency diseases; genetically altered cells and cell lines for use in the production of human therapeutic proteins, for medical diagnostic use, for use in the treatment of a variety of diseases and disorders and for implantation into human patients
Pseudo MarkGAEPO

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 17, 1998
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTranskaryotic Therapies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameTranskaryotic Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, September 23, 2003ABANDONMENT - NO USE STATEMENT FILED
Monday, March 24, 2003EXTENSION 5 GRANTED
Thursday, January 16, 2003EXTENSION 5 FILED
Thursday, January 16, 2003TEAS EXTENSION RECEIVED
Wednesday, July 17, 2002EXTENSION 4 GRANTED
Wednesday, July 17, 2002EXTENSION 4 FILED
Tuesday, July 16, 2002TEAS EXTENSION RECEIVED
Monday, February 11, 2002EXTENSION 3 GRANTED
Thursday, January 24, 2002EXTENSION 3 FILED
Wednesday, July 25, 2001EXTENSION 2 GRANTED
Friday, July 13, 2001EXTENSION 2 FILED
Monday, January 22, 2001EXTENSION 1 GRANTED
Monday, November 20, 2000EXTENSION 1 FILED
Tuesday, July 25, 2000NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 2, 2000PUBLISHED FOR OPPOSITION
Friday, March 31, 2000NOTICE OF PUBLICATION
Wednesday, December 8, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 9, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 5, 1999NON-FINAL ACTION MAILED
Tuesday, February 9, 1999ASSIGNED TO EXAMINER
Monday, February 8, 1999ASSIGNED TO EXAMINER
Monday, November 16, 1998CORRESPONDENCE RECEIVED IN LAW OFFICE